Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress. (Q50516147)

14 March 2018

title

Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress. (English)

1 reference

14 March 2018

author name string

Varadarajan S

1

1 reference

14 March 2018

Yatin S

2

1 reference

14 March 2018

Kanski J

3

1 reference

14 March 2018

Jahanshahi F

4

1 reference

14 March 2018

Butterfield DA

5

1 reference

14 March 2018

publication date

1 September 1999

1 reference

14 March 2018

published in

Brain Research Bulletin

1 reference

14 March 2018

volume

50

1 reference

14 March 2018

page(s)

133-141

1 reference

14 March 2018

issue

2

1 reference

14 March 2018

Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Vitamin E protects nerve cells from amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Spin trapping: ESR parameters of spin adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Melatonin prevents beta-amyloid-induced lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Amyloid beta peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

In vivo aggregation of beta-amyloid peptide variants

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Determination of carbonyl content in oxidatively modified proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Carbonyl assays for determination of oxidatively modified proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

beta-Amyloid-induced toxicity in rat hippocampal cells: in vitro evidence for the involvement of free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

beta-Amyloid peptide in vitro toxicity: lot-to-lot variability

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Alzheimer's disease: a central role for amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Amyloid beta-protein and the genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Two conformational states of amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Reactive oxygen-mediated protein oxidation in aging and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Oxidation of methionyl residues in proteins: tools, targets, and reversal

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Alzheimer's amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900093-3

7 January 2021

10.1016/S0361-9230(99)00093-3

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

10535332

1 reference

14 March 2018